Brief: Abbisko Cayman Says Center For Drug Evaluation Cleared IND Application For Absk131
06/03/2025 14:35
March 6 (Reuters) - Abbisko Cayman Ltd 2256.HK: CENTER FOR DRUG EVALUATION OF CHINA NMPA CLEARED IND APPLICATION FOR ABSK131 Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly